☆ 4.7 Editorial Material

DBS for Parkinson's disease with behavioural disturbances

LANCET NEUROLOGY (2018)

期刊

LANCET NEUROLOGY

卷 17, 期 3, 页码 195-197

出版社

ELSEVIER SCIENCE INC

DOI: 10.1016/S1474-4422(18)30044-9

关键词

-

类别

Clinical Neurology

资金

Spanish Science and Education Ministry
European Union (REPLACES)

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Clinical Neurology

Evoked potentials generated by deep brain stimulation for Parkinson's disease

Jahrane Dale, Stephen L. Schmidt, Kyle Mitchell, Dennis A. Turner, Warren M. Grill

Summary: This review describes the general features, mechanisms, technical recording factors, and clinical applications of brain evoked potentials (EPs) generated by deep brain stimulation (DBS) for Parkinson's disease (PD). DBS-evoked potentials arise from a complex integration of antidromic and orthodromic conduction pathway responses and provide valuable information for understanding the mechanisms and circuits involved in symptom treatment. These signals may serve as biomarkers for improving DBS outcomes and function. However, there are still critical gaps in our understanding of the mechanisms and clinical application of DBS-induced EPs.

BRAIN STIMULATION (2022)

添加到收藏夹

Review Neurosciences

Troubleshooting Gait Disturbances in Parkinson's Disease With Deep Brain Stimulation

Nicolo G. Pozzi, Chiara Palmisano, Martin M. Reich, Philip Capetian, Claudio Pacchetti, Jens Volkmann, Ioannis U. Isaias

Summary: This review discusses the issue of gait disturbances in Parkinson's disease patients undergoing deep brain stimulation (DBS) of the subthalamic nucleus or the globus pallidus. It mentions that gait disturbances may be related to disease progression, but they can also be caused by treatable factors and can benefit from DBS reprogramming.

FRONTIERS IN HUMAN NEUROSCIENCE (2022)

添加到收藏夹

Article Neurosciences

Spectral and spatial distribution of subthalamic beta peak activity in Parkinson's disease patients

Natasha Darcy, Roxanne Lofredi, Bassam Al-Fatly, Wolf-Julian Neumann, Julius Huebl, Christof Bruecke, Patricia Krause, Gerd-Helge Schneider, Andrea Kuehn

Summary: This report provides robust evidence that spectral peaks in the beta frequency range can be detected in the majority of subthalamic nuclei in Parkinson's disease patients, increasing confidence in the broad applicability of beta-guided deep brain stimulation.

EXPERIMENTAL NEUROLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Plasma Metabolic Disturbances in Parkinson's Disease Patients

Paulina Gatarek, Joanna Sekulska-Nalewajko, Barbara Bobrowska-Korczaka, Malgorzata Pawelczyk, Karol Jastrzebski, Andrzej Glabinski, Joanna Kaluzna-Czaplinska

Summary: Plasma metabolome analysis can provide valuable information on altered metabolites in patients with Parkinson's disease (PD). This study identified a panel of metabolites that could discriminate PD from controls with high accuracy and revealed metabolic pathways associated with the pathophysiology of PD.

BIOMEDICINES (2022)

添加到收藏夹

Article Clinical Neurology

Microsleep disturbances are associated with noradrenergic dysfunction in Parkinson's disease

Christopher E. J. Doppler, Julia A. M. Smit, Maximilian Hommelsen, Aline Seger, Jacob Horsager, Martin B. Kinnerup, Allan K. Hansen, Tatyana D. Fedorova, Karoline Knudsen, Marit Otto, Adjmal Nahimi, Per Borghammer, Michael Sommerauer

Summary: This study aimed to investigate changes in sleep microstructure and their relation to alterations in the noradrenergic system in Parkinson's disease (PD) patients. Results revealed that sleep microstructure is more severely affected than macrostructure in PD patients and is associated with widespread dysfunction of the noradrenergic arousal system.

SLEEP (2021)

添加到收藏夹

Article Clinical Neurology

Feasibility of local field potential-guided programming for deep brain stimulation in Parkinson's disease: A comparison with clinical and neuro-imaging guided approaches in a randomized, controlled pilot trial

Tobias Binder, Florian Lange, Nicolo Pozzi, Thomas Musacchio, Christine Daniels, Thorsten Odorfer, Patrick Fricke, Cordula Matthies, Jens Volkmann, Philipp Capetian

Summary: This study investigated the potential advantages of beta-guided programming in STN-DBS for Parkinson's disease. The results showed that beta-guided programming had similar clinical efficacy compared to clinically and image-guided programming, but required significantly less time. This new method has the potential to improve current clinical practice in DBS programming.

BRAIN STIMULATION (2023)

添加到收藏夹

Article Clinical Neurology

Long term follow-up in advanced Parkinson's disease treated with DBS of the subthalamic nucleus

Maria Antonietta Volonte, Giacomo Clarizio, Sebastiano Galantucci, Pietro Giuseppe Scamarcia, Rosalinda Cardamone, Lina Raffaella Barzaghi, Monica Falautano, Pietro Mortini, Giancarlo Comi, Massimo Filippi

Summary: This study evaluated the long-term effectiveness of STN-DBS treatment on advanced PD patients over a span of 14 years. Results showed significant improvement in tremor, rigidity, and daily dopaminergic dose, but no lasting effect on axial symptoms and cognitive functions. STN-DBS remains an effective therapy for advanced PD patients, extending the period of acceptable quality of life despite disease progression.

JOURNAL OF NEUROLOGY (2021)

添加到收藏夹

Article Neurosciences

STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson's Disease

Matteo Conti, Alessandro Stefani, Roberta Bovenzi, Rocco Cerroni, Elena Garasto, Fabio Placidi, Claudio Liguori, Tommaso Schirinzi, Nicola B. Mercuri, Mariangela Pierantozzi

Summary: In this study, the short-term effects of subthalamic nucleus deep-brain stimulation (STN-DBS) on beta-band cortical functional connectivity (FC) were investigated in Parkinson's disease (PD) patients. The results showed that PD patients exhibited widespread cortical hyperconnectivity in beta bands, and STN-DBS could acutely reduce beta FC primarily in cortical regions involved in basal ganglia-cortical circuits.

BRAIN SCIENCES (2022)

添加到收藏夹

Article Clinical Neurology

Capturing Initial Understanding and Impressions of Surgical Therapy for Parkinson's Disease

Somnath Das, Caio M. Matias, Sunidhi Ramesh, Lohit Velagapudi, Julie P. Barbera, Samantha Katz, Michael P. Baldassari, Mohammad Rasool, Daniel Kremens, Jeffrey Ratliff, Tsao-Wei Liang, Chengyuan Wu

Summary: PD patients seen at an urban movement disorders clinic expressed concerns regarding the efficacy, invasiveness, cost, and irreversibility of DBS, independent of the original source of information. Most patients considered DBS to be an effective treatment for PD, but were also worried about potential negative effects of the surgery.

FRONTIERS IN NEUROLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson's Disease

Juan F. Cervilla-Martinez, Juan J. Rodriguez-Gotor, Krzysztof J. Wypijewski, Angela Fontan-Lozano, Tao Wang, Enrique Santamaria, William Fuller, Rebeca Mejias

Summary: Through data-mining of palmitome in the cerebral cortex of PD patients and controls, the study identified 150 proteins with altered palmitoylation, which are predicted to impact cytoskeleton, mitochondrial and fibrinogen functions, as well as cell survival. The research suggests that protein palmitoylation may play a role in the pathophysiology of PD, and comprehensive palmitoyl-proteomics is a powerful approach for exploring novel cellular pathways involved in this neurodegenerative disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Neurosciences

Global Variability in Deep Brain Stimulation Practices for Parkinson's Disease

Abhimanyu Mahajan, Ankur Butala, Michael S. Okun, Zoltan Mari, Kelly A. Mills

Summary: The study revealed a high variability in approaches for DBS candidate selection, brain target selection, procedure type, and postoperative practices. Cognitive and mood assessments were underutilized and there was low reliance on multidisciplinary teams or psychosocial factors in the decision-making process. Prospective studies are needed to inform evidence-based guidelines.

FRONTIERS IN HUMAN NEUROSCIENCE (2021)

添加到收藏夹

Review Clinical Neurology

Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease

Eiko N. Minakawa

Summary: Parkinson's disease and Alzheimer's disease are both common neurodegenerative diseases that lead to the gradual deterioration of neurological and psychiatric symptoms. Sleep disturbances play a significant role in the onset and progression of these diseases.

FRONTIERS IN NEUROLOGY (2022)

添加到收藏夹

Review Neurosciences

The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson's disease

Faisal Alosaimi, Jackson Tyler Boonstra, Sonny Tan, Yasin Temel, Ali Jahanshahi

Summary: DBS is a successful paradigm for treating movement disorders, but its specific mechanisms and effects on neurotransmitter dynamics are still not fully understood. This review discusses the role of neurotransmitter dynamics in mediating DBS effects in Parkinson's disease.

FRONTIERS IN NEUROSCIENCE (2022)

添加到收藏夹

Article Clinical Neurology

Short- and long-term motor outcome of STN-DBS in Parkinson's Disease: focus on sex differences

Nico Golfre Andreasi, Luigi Michele Romito, Roberta Telese, Roberto Cilia, Antonio Emanuele Elia, Alessio Novelli, Giovanni Tringali, Giuseppe Messina, Vincenzo Levi, Grazia Devigili, Sara Rinaldo, Angelo Amato Franzini, Roberto Eleopra

Summary: STN-DBS has a long-lasting effect on motor complications in both male and female PD patients, but there may be slight differences in certain aspects that require further investigation.

NEUROLOGICAL SCIENCES (2022)

添加到收藏夹

Article Clinical Neurology

Short- and Long-Term Effects of DBS on Gait in Parkinson's Disease

Hana Brozova, Isabelle Barnaure, Evzen Ruzicka, Jan Stochl, Ron Alterman, Michele Tagliati

Summary: The study aimed to compare the short and long-term effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on gait dysfunction and other cardinal symptoms of Parkinson's disease (PD). The results showed that short-term improvement of gait abnormalities appears to significantly decline after 5 years of STN DBS in PD patients, while effectiveness for other symptoms remains stable. This suggests that non-dopaminergic mechanisms or deleterious effects of high frequency STN stimulation might play a role in the decline of gait function over time.

FRONTIERS IN NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Impact of advanced Parkinson's disease on caregivers: an international real-world study

Pablo Martinez-Martin, Matej Skorvanek, Tove Henriksen, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Prasanna L. L. Kandukuri, Vivek S. S. Chaudhari, Apeksha B. B. Patel, Juan Carlos Parra, James Pike, Angelo Antonini

Summary: This study examines the impact of advanced Parkinson's disease (APD) on caregiver burden, quality of life (QoL), and health status. The results show that caregivers of people with APD experience a greater burden, are less satisfied with treatment, and spend more time caregiving.

JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Article Neurosciences

Modulation of Motor Vigor by Expectation of Reward Probability Trial-by-Trial Is Preserved in Healthy Ageing and Parkinson?s Disease Patients

Margherita Tecilla, Michael Grossbach, Giovanni Gentile, Peter Holland, Sebastian Sporn, Angelo Antonini, Maria Herrojo Ruiz

Summary: This study examines the impact of dynamically inferring action-reward contingencies on motor performance. The results show that stronger predictions about the tendency of the action-reward contingency lead to faster movement tempo, but have little effect on reaction time. Additionally, we found no significant differences in this effect between age and Parkinson's disease.

JOURNAL OF NEUROSCIENCE (2023)

添加到收藏夹

Letter Clinical Neurology

Confusion of evidence-based reviews and guidelines

Gunther Deuschl, Angelo Antonini, Joao Costa, Katarzyna Smilowska, Daniela Berg, Jean-Christophe Corvol, Giovanni Fabbrini, Joaquim Ferreira, Tom Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evzen Ruzicka, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro

EUROPEAN JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Letter Clinical Neurology

Confusion of Evidence-Based Reviews and Guidelines

Guenther Deuschl, Angelo Antonini, Joao Costa, Katarzyna Smilowska, Daniela Berg, Jean-Christophe Corvol, Giovanni Fabbrini, Joaquim Ferreira, Tom Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evzen Ruzicka, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro

MOVEMENT DISORDERS (2023)

添加到收藏夹

Review Clinical Neurology

Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

Stefanie Jost, Marie-Ann Kaldenbach, Angelo Antonini, Pablo Martinez-Martin, Lars Timmermann, Per Odin, Regina Katzenschlager, Rupam Borgohain, Alfonso Fasano, Fabrizio Stocchi, Nobutaka Hattori, Prashanth Lingappa Kukkle, Mayela Rodriguez-Violante, Cristian Falup-Pecurariu, Sebastian Schade, Jan Niklas Petry-Schmelzer, Vinod Metta, Daniel Weintraub, Guenther J. Deuschl, Alberto J. Espay, Eng-King Tan, Roongroj Bhidayasiri, Victor S. C. Fung, Francisco Cardoso, Claudia Trenkwalder, Peter Jenner, K. S. Ray Chaudhuri, Haidar Dafsari

Summary: This study reviewed the investigations on drug therapy for Parkinson's disease since 2010 and proposed a new drug conversion formula. These conversion formulas can help us compare drug regimens across different clinical trials. The results are important for studying the pharmacological efficacy of Parkinson's disease treatments as well as other non-pharmacological interventions.

MOVEMENT DISORDERS (2023)

添加到收藏夹

Article Clinical Neurology

Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease

Aron Emmi, Michele Sandre, Francesco Paolo Russo, Giulia Tombesi, Federica Garri, Marta Campagnolo, Miryam Carecchio, Roberta Biundo, Gaya Spolverato, Veronica Macchi, Edoardo Savarino, Fabio Farinati, Piero Parchi, Andrea Porzionato, Luigi Bubacco, Raffaele De Caro, Gabor G. Kovacs, Angelo Antonini

Summary: This study revealed the presence of neuronal dysfunction and reactive gliosis in the duodenum of patients with Parkinson's disease, suggesting that the enteric nervous system is involved in the pathophysiology of the disease.

MOVEMENT DISORDERS (2023)

添加到收藏夹

Article Neurosciences

NF-?B/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson?s disease patients

Vanessa Porrini, Andrea Pilotto, Marika Vezzoli, Annamaria Lanzillotta, Michele M. Gennari, Sonia Bonacina, Antonella Alberici, Rosanna Turrone, Arianna Bellucci, Angelo Antonini, Alessandro Padovani, Marina Pizzi

Summary: Although the key neuropathological hallmarks of Parkinson's disease (PD) are known, the underlying pathogenic mechanisms of the disease still need to be elucidated. This study focused on evaluating the levels and activity of c-Rel protein, which may be involved in PD pathophysiology. The findings suggest that PD is characterized by the loss of NF-κB/c-Rel activity, and the reduction of c-Rel DNA-binding could potentially serve as a novel biomarker for PD.

NEUROBIOLOGY OF DISEASE (2023)

添加到收藏夹

Correction Clinical Neurology

A case of childhood-onset dystonia-parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation (May, 10.1007/s10072-023-06832-7, 2023)

Federica Garri, Dario Ciprietti, Lisa Lerjefors, Andrea Landi, Manuela Pilleri, Roberta Biundo, Leonardo Salviati, Miryam Carecchio, Angelo Antonini

NEUROLOGICAL SCIENCES (2023)

添加到收藏夹

Article Clinical Neurology

Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management

Fabrizio Stocchi, Paolo Barone, Giuseppe Bellelli, Andrea Fagiolini, Luigi Ferini Strambi, Sandro Sorbi, Alessandro Padovani

Summary: The diagnosis of depression in Parkinson's disease is challenging due to overlapping symptoms. A panel of Italian specialists reached a consensus that depression is a risk factor for Parkinson's disease, with neuropathological abnormalities playing a role. Multimodal and SSRI antidepressants are confirmed as effective options for treating depression in Parkinson's disease.

NEUROLOGICAL SCIENCES (2023)

添加到收藏夹

Article Clinical Neurology

Toward objective monitoring of Parkinson's disease motor symptoms using a wearable device: wearability and performance evaluation of PDMonitor®

Angelo Antonini, Heinz Reichmann, Giovanni Gentile, Michela Garon, Chiara Tedesco, Anika Frank, Bjoern Falkenburger, Spyridon Konitsiotis, Konstantinos Tsamis, Georgios Rigas, Nicholas Kostikis, Adamantios Ntanis, Constantinos Pattichis

Summary: This article describes the results of two clinical studies validating the performance of a new wearable monitoring device, PDMonitor, in detecting Parkinson's disease-related motor symptoms. The studies demonstrated high accuracy and correlation between the severity of symptoms and expert evaluations, confirming the effectiveness of the system as a continuous telemonitoring solution for facilitating treatment decisions in patients with Parkinson's disease.

FRONTIERS IN NEUROLOGY (2023)

添加到收藏夹

Review Neurosciences

Combining Transcranial Magnetic Stimulation and Deep Brain Stimulation: Current Knowledge, Relevance and Future Perspectives

Valentina D'Onofrio, Nicoletta Manzo, Andrea Guerra, Andrea Landi, Valentina Baro, Sara Maeaettae, Luca Weis, Camillo Porcaro, Maurizio Corbetta, Angelo Antonini, Florinda Ferreri

Summary: Deep brain stimulation (DBS) is a promising treatment for neurological disorders, but its mechanisms of action are not fully understood. Transcranial magnetic stimulation (TMS) combined with DBS provides a unique approach to investigate the neurophysiology of the brain. Experimental studies have shown that DBS modulates cortical excitability and plasticity, which may contribute to its therapeutic effects. However, safety concerns limit the application of the TMS-DBS approach.

BRAIN SCIENCES (2023)

添加到收藏夹

Article Neurosciences

Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei

Aron Emmi, Stefania Rizzo, Luisa Barzon, Michele Sandre, Elisa Carturan, Alessandro Sinigaglia, Silvia Riccetti, Mila Della Barbera, Rafael Boscolo-Berto, Patrizia Cocco, Veronica Macchi, Angelo Antonini, Monica De Gaspari, Cristina Basso, Raffaele De Caro, Andrea Porzionato

Summary: Neurological manifestations are common in COVID-19 patients, and this study found evidence of SARS-CoV-2 infection in the central nervous system. The researchers observed viral RNA and SARS-CoV-2-immunoreactive neurons in specific regions of the brain in COVID-19 patients. In addition, inflammation was observed in affected brainstem regions, indicating a role of brainstem inflammation in COVID-19. Further investigations are needed to understand the potential implications for neurodegenerative diseases like Parkinson's.

NPJ PARKINSONS DISEASE (2023)

添加到收藏夹

Review Clinical Neurology

Current and novel infusion therapies for patients with Parkinson & apos;s disease

Angelo Antonini, Valentina D'Onofrio, Andrea Guerra

Summary: Advanced Parkinson's disease patients often experience poor mobility and functional decline despite medication adjustments. Drug delivery systems have been developed to bypass issues with oral levodopa absorption and have been proven effective in trials and real-world use. Future efforts should focus on early detection and global availability of these treatments.

JOURNAL OF NEURAL TRANSMISSION (2023)

添加到收藏夹

Article Immunology

Persistent and transient olfactory deficits in COVID-19 are associated to inflammation and zinc homeostasis

Lorenzo Lupi, Anna Bordin, Gabriele Sales, Davide Colaianni, Adriana Vitiello, Alberto Biscontin, Alberto Reale, Alfredo Garzino-Demo, Angelo Antonini, Giancarlo Ottaviano, Carla Mucignat, Cristina Parolin, Arianna Calistri, Cristiano De Pitta

Summary: COVID-19 is a respiratory syndrome that can cause various symptoms, including deficits in smell and taste. Transcriptome analysis of olfactory mucosa revealed altered gene expression levels in patients with persistent olfactory deficits, with associations with inflammatory response and zinc homeostasis.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study

Jason Aldred, Eric Freire-Alvarez, Alexander V. Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K. Ray Chaudhuri, Susan R. Criswell, Erik H. Danielsen, Florin Gandor, Jia Jia, Thomas E. Kimber, Hideki Mochizuki, Weining Z. Robieson, Amy M. Spiegel, David G. Standaert, Saritha Talapala, Maurizio F. Facheris, Victor S. C. Fung

Summary: This article reports the results of a 52-week open-label registrational trial that evaluated the safety, tolerability, and efficacy of 24-hour foslevodopa/foscarbidopa continuous subcutaneous infusion in patients with advanced Parkinson's disease. The findings suggest that this treatment has the potential to improve motor control, sleep quality, and quality of life in patients with Parkinson's disease.

NEUROLOGY AND THERAPY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.